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Abstract 
Sleep-disordered breathing (SDB) in children causes multiple health problems and diminished 
quality of life. It is usually caused by tonsil and adenoid hypertrophy and is traditionally treated 
with adenotonsillar surgery. The aims of the first paper were to examine the prevalence of SDB 
in Swedish children and the extent to which these children attract the attention of the health-care 
system. Further aims of the thesis were to examine different aspects of diagnostics and 
treatment, such as the quality and usefulness of at-home respiratory polygraphy, the health-
economic aspects of tonsil surgery and the effect of nasal steroid treatment on symptoms and 
health-related quality of life in children with SDB. 
Methods/Results: Paper I is a population-based, cross-sectional study in which 1,320 randomly 
selected Swedish children, aged 0-11, received questionnaires regarding symptoms of SDB in 
the previous month, health-care contacts and general health; 4.8% of the children had frequent 
SDB symptoms. Of these children, only 31% had been in contact with the health-care system 
due to their SDB symptoms. Paper II: A retrospective register study was conducted on all 
children aged 1-11 years that had tonsil surgery due to upper airway obstruction in 2011 and 
were included in the National Tonsil Surgery Register in Sweden (NTSRS), n=4,534. The mean 
duration of analgesic treatment was 4.6 days and the mean number of days with temporary 
parental benefits from the Social Insurance Agency was 2.9 days. The indirect costs were 61% 
higher after tonsillectomy than after tonsillotomy, due to a shorter recovery time after 
tonsillotomy. Paper III is a randomised, placebo-controlled study that comprised 60 children 
with SDB, aged 4-10 years. They were treated with budesonide or placebo nasal spray for six 
weeks. The improvement in health-related quality of life, measured by the OSA-18 total score, 
was significantly greater in the budesonide group than in the placebo group. The VAS scores for 
quality of life, as well as snoring, apneas and nasal obstruction, improved after budesonide 
treatment. In Paper IV, the quality of the at-home respiratory polygraphies performed on the 
children in Paper III was analysed and found to be poor, most often due to a missing nasal 
airflow signal. In an analysis of 17 polygraphies of good quality, the interrater correlation 
between two independent scorers was moderately good, but, when the nasal airflow signal was 
excluded and the scores for respiratory events were based on RIP flow, the correlation was 
negatively affected. 
Conclusions: Many children with SDB do not get an appropriate evaluation and treatment. The 
costs for parental absenteeism after tonsillotomy are lower than after tonsillectomy. Nasal ster-
oid treatment is effective in children with mild to moderate SDB. The quality and reliability of 
at-home respiratory polygraphy in children with SDB is questionable and needs further evalua-
tion. 
